ESMO 2023 Insights: "Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial - Combination of Durvalumab With Standard 1L Chemo +/- Olaparib in Patients With Advanced Endometrial Cancer"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESMO 2023 Insights: "Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial - Combination of Durvalumab With Standard 1L Chemo +/- Olaparib in Patients With Advanced Endometrial Cancer"

By ecancer FEATURING Shannon Westin

162 views

October 25, 2023

0 Comments

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza

17:50

AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde

08:16

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification W…

Feat. A. Clements

15:14

Brian Slomovitz

Update in Vulvar and Vaginal Cancer

09:41

Insights from 2024 SGO Annual Meeting

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Feat. M. Raza Mirza

08:45

Total Health

Recent Highlights in Endometrial Cancer

Feat. B. Slomovitz

16:37

Total Health

2024 Updates in Uterine/Endometrial Cancer

Feat. T. Tillmanns

11:19

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlima…

Feat. M. Raza Mirza

10:35

UCLA Health

Updates in Endometrial Cancer

Feat. R. Salani

07:24

Fengting Yan

Year in Review: Endometrial Cancer

07:25

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenanc…

Feat. B. Corr

44:59

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Updates on Cervical and Endometrial Cancers

Feat. K. Pennington

18:46

OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard

27:12

OncoAlert

New Endometrial Cancer FIGO Staging System in the Era of Molecular C…

Feat. N. Concin

12:55

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Integrating Immunotherapy Into the Treatment of Endometrial Cancer

Feat. A. Wright

14:09

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 DUO-E/GOG-3041/ENGOT-EN10 Trial - …

Feat. S. Westin

09:29

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 RUBY Trial - Dostarlimab + Chemoth…

Feat. M. Raza Mirza

05:32

Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi

05:46

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Platinum-Free Interval & Response to Pl…

Feat. P. Haight

10:27

Robert McBane

Login

Login

Join VuMedi

ESMO 2023 Insights: "Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial - Combination of Durvalumab With Standard 1L Chemo +/- Olaparib in Patients With Advanced Endometrial Cancer"

Related Content